PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
6.30%
Growth of 6.30% while CRWV shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
4.14%
Cost growth of 4.14% while CRWV maintains flat costs. Bruce Berkowitz would investigate efficiency gap.
7.26%
Growth of 7.26% while CRWV shows flat gross profit. Bruce Berkowitz would examine quality advantage.
0.90%
Margin change of 0.90% while CRWV shows flat margins. Bruce Berkowitz would examine quality advantage.
-3.51%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
33.72%
G&A change of 33.72% while CRWV maintains overhead. Bruce Berkowitz would investigate efficiency.
7.90%
Marketing expense change of 7.90% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
34.41%
Other expenses change of 34.41% while CRWV maintains costs. Bruce Berkowitz would investigate efficiency.
5.31%
Operating expenses change of 5.31% while CRWV maintains costs. Bruce Berkowitz would investigate control.
4.69%
Total costs change of 4.69% while CRWV maintains costs. Bruce Berkowitz would investigate control.
-2.82%
Interest expense reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine advantage.
9.16%
D&A change of 9.16% while CRWV maintains D&A. Bruce Berkowitz would investigate efficiency.
12.29%
EBITDA change of 12.29% while CRWV is flat. Bruce Berkowitz would examine quality.
2.63%
Margin change of 2.63% while CRWV is flat. Bruce Berkowitz would examine quality.
8.51%
Income change of 8.51% while CRWV is flat. Bruce Berkowitz would examine quality.
2.07%
Margin change of 2.07% while CRWV is flat. Bruce Berkowitz would examine quality.
47.35%
Other expenses change of 47.35% while CRWV maintains costs. Bruce Berkowitz would investigate control.
9.06%
Income change of 9.06% while CRWV is flat. Bruce Berkowitz would examine quality.
2.59%
Margin change of 2.59% while CRWV is flat. Bruce Berkowitz would examine quality.
6.22%
Tax expense change of 6.22% while CRWV maintains burden. Bruce Berkowitz would investigate strategy.
9.74%
Income change of 9.74% while CRWV is flat. Bruce Berkowitz would examine quality.
3.23%
Margin change of 3.23% while CRWV is flat. Bruce Berkowitz would examine quality.
9.76%
EPS change of 9.76% while CRWV is flat. Bruce Berkowitz would examine quality.
9.80%
Diluted EPS change of 9.80% while CRWV is flat. Bruce Berkowitz would examine quality.
-0.09%
Share count reduction while CRWV shows 0.00% change. Joel Greenblatt would examine strategy.
0.04%
Diluted share change of 0.04% while CRWV is stable. Bruce Berkowitz would verify approach.